Fetal Akinesia/Hypokinesia and Arthrogryposis of Neuromuscular Origin: Etiologic Groups, Genetics, and Phenotypic Spectrum
Annals of Clinical and Translational Neurology · 2025-08 · 12 (8) · 1528-1547
DOI: 10.1002/acn3.70088 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 29.05.2025. Verfasst von Florencia Pérez-Vidarte und 13 weiteren Autor:innen. Beteiligte Einrichtung: Neuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain. Hauptthemen laut MEDLINE: Arthrogryposis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
Objective
To provide a comprehensive clinical and genetic characterization of individuals with arthrogryposis multiplex congenita (AMC), focusing on the distribution of genetic etiologies across the neuromuscular spectrum and comparing myogenic and neurogenic subtypes.
Methods
A total of 105 individuals with AMC were clinically and genetically evaluated in a single‐center study. Participants were stratified based on the primary site of involvement, and further classification was performed for neuromuscular cases into neurogenic and myogenic subtypes. Genetic diagnoses were made through using a range of next‐generation sequencing techniques, including exome sequencing (42 individuals), gene panel testing (40 individuals), genome sequencing (24 individuals), and targeted‐gene testing in selected cases. In most individuals who underwent genome sequencing, this was preceded by exome or gene panel testing.
Results
Of the 105 individuals, 4 were classified as Amyoplasia and 1 as FARAD. Among the remaining 100 cases, 81 (81%) presented with neuromuscular AMC, with defects involving motor neurons/peripheral nerves (52%, 42/81), neuromuscular junctions (7%, 6/81), and skeletal muscle (41%, 33/81). A genetic diagnosis was achieved in 55% (55/100) of the entire cohort and in 58% (47/81) of individuals with neuromuscular AMC. The most frequently implicated genes were TTN (16%, 9/55), CHRNG (10.9%, 6/55), PIEZO2 (9.1%, 5/55), ZC4H2 (9.1%, 5/55), DYNC1H1 (7.2%, 4/55), MYH3 (5.4%, 3/55), and RYR1 (5.4%, 3/55). Diagnostic yield varied significantly between subgroups, with 84.6% (33/39) of myogenic AMC cases genetically resolved, compared to 33.3% (14/42) of neurogenic cases. TTN was the most common gene in myogenic AMC, while ZC4H2 and DYNC1H1 were predominant in neurogenic AMC.
Interpretation
This study provides a detailed phenotypic and genetic characterization of neuromuscular AMC, highlighting the most frequently affected genes and their associated phenotypes. The findings underscore the challenges in diagnosing a significant proportion of cases, especially within the neurogenic subgroup, and emphasize the importance of integrating detailed phenotypic data with genetic analysis to enhance diagnosis, prognosis, and management of family expectations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
- Laboratory of Neurogenetics and Molecular Medicine, Center for Genomic Sciences in Medicine, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
- Centro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.
- Universitat de Barcelona (UB), Barcelona, Spain.
- Center for Biomedical Research Network on Rare Diseases (CIBERER), ISCIII, Spain.
- Department of Genetic and Molecular Medicine, Hospital Sant Joan de Déu, Barcelona, Spain.
ORCID-Profile: Florencia Pérez-Vidarte, Berta Estévez-Arias, Daniel Natera-de Benito
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Pérez-Vidarte, F., Estévez-Arias, B., Matalonga, L., Yubero, D., Codina, A., Ortez, C., Medina, J., DeSena DeCabo, L., Carrera-García, L., Expósito-Escudero, J., Jou, C., Tizzano, E. F., Nascimento, A., & Natera-de Benito, D. (2025). Fetal Akinesia/Hypokinesia and Arthrogryposis of Neuromuscular Origin: Etiologic Groups, Genetics, and Phenotypic Spectrum. Annals of Clinical and Translational Neurology, 12(8), 1528-1547. https://doi.org/10.1002/acn3.70088
Vancouver
Pérez-Vidarte F, Estévez-Arias B, Matalonga L, Yubero D, Codina A, Ortez C, et al. Fetal Akinesia/Hypokinesia and Arthrogryposis of Neuromuscular Origin: Etiologic Groups, Genetics, and Phenotypic Spectrum. Annals of Clinical and Translational Neurology. 2025;12(8):1528-1547. doi:10.1002/acn3.70088
BibTeX
@article{PrezVidarte2025,
author = {Pérez-Vidarte, Florencia and Estévez-Arias, Berta and Matalonga, Leslie and Yubero, Delia and Codina, Anna and Ortez, Carlos and Medina, Julita and DeSena DeCabo, Lidia and Carrera-García, Laura and Expósito-Escudero, Jesica and Jou, Cristina and Tizzano, Eduardo F and Nascimento, Andres and Natera-de Benito, Daniel},
title = {Fetal Akinesia/Hypokinesia and Arthrogryposis of Neuromuscular Origin: Etiologic Groups, Genetics, and Phenotypic Spectrum},
journal = {Annals of Clinical and Translational Neurology},
year = {2025},
volume = {12},
number = {8},
pages = {1528--1547},
doi = {10.1002/acn3.70088}
}
EUVIMED